A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice

NCT02545465 · clinicaltrials.gov ↗

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Riociguat (Adempas, BAY63-2521)

Sponsor

Bayer